Biotricity raises $15M in underwritten public offering, lists on Nasdaq Capital Market

BIOTRICITY INC.

Offered 5M shares at $3.00/share for ~$15M gross proceeds; H.C. Wainwright sole book-runner.
Closing on August 30, 2021; underwriter partially exercised over-allotment for 48,000 additional shares.
Shares began trading on Nasdaq Capital Market on August 26, 2021 under ticker BTCY.
Net proceeds to be used for general corporate purposes, including working capital and potential acquisitions.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.